paediatrics Archives -

A pooled analysis of data for AstraZeneca and Sanofi’s respiratory syncytial virus (RSV) antibody nirsevimab has concluded that

AZ, Sanofi build case for one-shot RSV antibody

https://pharmaphorum.com/news/az-sanofi-build-case-for-one-shot-rsv-antibody/

A study has shown that a mobile game can be used to gather symptom data from children undergoing

Game used to track symptoms in children with cancer

https://pharmaphorum.com/news/game-used-to-track-symptoms-in-children-with-cancer/

Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a

Pfizer bulks up in RSV with $525m takeover of ReViral

https://pharmaphorum.com/news/pfizer-bulks-up-in-rsv-with-525m-takeover-of-reviral/

Hard on the heels of some impressive clinical trial results, Luminopia has won FDA approval for its digital

Luminopia scores FDA approval for TV-based amblyopia therapy

https://pharmaphorum.com/news/luminopia-scores-fda-approval-for-tv-based-amblyopia-therapy/

Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for

Limbix’ digital therapeutic cuts depression symptoms in young people

https://pharmaphorum.com/news/limbix-digital-therapeutic-cuts-depression-symptoms-in-young-people/

The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and

MHRA clears Moderna COVID vaccine for 12 to 17 year olds

https://pharmaphorum.com/news/mhra-clears-moderna-covid-vaccine-for-12-to-17-year-olds/

An attempt by Pfizer to extend the uses of its pulmonary artery hypertension (PAH) drug Revatio into a

Pfizer’s Revatio flunks paediatric hypertension study

https://pharmaphorum.com/news/pfizers-revatio-flunks-paediatric-hypertension-study/

FDA and EMA hope to streamline development of paediatric plans.

FDA and EMA to work more closely on paediatric drug regulation

https://pharmaphorum.com/news/eu-us-paediatric-launch-parallel/

paediatrics